406 related articles for article (PubMed ID: 37492224)
81. Breast cancer stem cells, EMT and therapeutic targets.
Kotiyal S; Bhattacharya S
Biochem Biophys Res Commun; 2014 Oct; 453(1):112-6. PubMed ID: 25261721
[TBL] [Abstract][Full Text] [Related]
82. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
[TBL] [Abstract][Full Text] [Related]
83. MicroRNAs, a Promising Target for Breast Cancer Stem Cells.
Das PK; Siddika MA; Asha SY; Aktar S; Rakib MA; Khanam JA; Pillai S; Islam F
Mol Diagn Ther; 2020 Feb; 24(1):69-83. PubMed ID: 31758333
[TBL] [Abstract][Full Text] [Related]
84. Breast Cancer Stem Cells.
Crabtree JS; Miele L
Biomedicines; 2018 Jul; 6(3):. PubMed ID: 30018256
[TBL] [Abstract][Full Text] [Related]
85. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.
Wei L; Liu TT; Wang HH; Hong HM; Yu AL; Feng HP; Chang WW
Breast Cancer Res; 2011 Oct; 13(5):R101. PubMed ID: 22023707
[TBL] [Abstract][Full Text] [Related]
86. Nuclear Factor Erythroid-Derived 2-Like 2-Induced Reductive Stress Favors Self-Renewal of Breast Cancer Stem-Like Cells
Kim DH; Jang JH; Kwon OS; Cha HJ; Youn HJ; Chun KS; Surh YJ
Antioxid Redox Signal; 2020 Jun; 32(18):1313-1329. PubMed ID: 31672029
[No Abstract] [Full Text] [Related]
87. Immunotargeting of Cancer Stem Cells.
Köseer AS; Di Gaetano S; Arndt C; Bachmann M; Dubrovska A
Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900399
[TBL] [Abstract][Full Text] [Related]
88. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.
Cai C; Zhu X
Mol Med Rep; 2012 May; 5(5):1191-6. PubMed ID: 22367735
[TBL] [Abstract][Full Text] [Related]
89. Self-renewal signaling pathways in breast cancer stem cells.
Nalla LV; Kalia K; Khairnar A
Int J Biochem Cell Biol; 2019 Feb; 107():140-153. PubMed ID: 30593953
[TBL] [Abstract][Full Text] [Related]
90. Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective.
Tang Y; Chen Y; Zhang Z; Tang B; Zhou Z; Chen H
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959397
[TBL] [Abstract][Full Text] [Related]
91. Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications.
Patni AP; Harishankar MK; Joseph JP; Sreeshma B; Jayaraj R; Devi A
Cell Oncol (Dordr); 2021 Jun; 44(3):473-494. PubMed ID: 33704672
[TBL] [Abstract][Full Text] [Related]
92. Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt β-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4.
Bhuvanalakshmi G; Basappa ; Rangappa KS; Dharmarajan A; Sethi G; Kumar AP; Warrier S
Front Pharmacol; 2017; 8():124. PubMed ID: 28373842
[No Abstract] [Full Text] [Related]
93. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
94. Bladder cancer stem cells: clonal origin and therapeutic perspectives.
Li Y; Lin K; Yang Z; Han N; Quan X; Guo X; Li C
Oncotarget; 2017 Sep; 8(39):66668-66679. PubMed ID: 29029546
[TBL] [Abstract][Full Text] [Related]
95. Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance.
Sridharan S; Howard CM; Tilley AMC; Subramaniyan B; Tiwari AK; Ruch RJ; Raman D
Front Oncol; 2019; 9():1003. PubMed ID: 31681564
[TBL] [Abstract][Full Text] [Related]
96. Breast cancer stem cells: Biology and therapeutic implications.
Butti R; Gunasekaran VP; Kumar TVS; Banerjee P; Kundu GC
Int J Biochem Cell Biol; 2019 Feb; 107():38-52. PubMed ID: 30529656
[TBL] [Abstract][Full Text] [Related]
97. Oncofetal proteins and cancer stem cells.
Yan Q; Fang X; Li C; Lan P; Guan X
Essays Biochem; 2022 Sep; 66(4):423-433. PubMed ID: 35670043
[TBL] [Abstract][Full Text] [Related]
98. Targeting the Key Signaling Pathways in Breast Cancer: From Molecular Mechanism to Therapeutic Interventions.
Singh D; Sahoo A
Recent Pat Anticancer Drug Discov; 2024 Jan; ():. PubMed ID: 38251701
[TBL] [Abstract][Full Text] [Related]
99. Hedgehog Signaling in the Maintenance of Cancer Stem Cells.
Cochrane CR; Szczepny A; Watkins DN; Cain JE
Cancers (Basel); 2015 Aug; 7(3):1554-85. PubMed ID: 26270676
[TBL] [Abstract][Full Text] [Related]
100. Deubiquitinating Enzyme-Mediated Signaling Networks in Cancer Stem Cells.
Kaushal K; Ramakrishna S
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33158118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
